Literature DB >> 9267354

Rupture of a dissecting aneurysm into the superior vena cava in Marfan's syndrome.

Y Toyoda1, C Yamashita, M Yoshida, H Nohara, K Okada, Y Otaki, M Okada.   

Abstract

Aneurysmal dilatation of the aorta with subsequent dissection or rupture occurs frequently in patients with Marfan's syndrome. These complications are among the major causes of death. We report the case of a 51-year-old man with annulo-aortic ectasia in Marfan's syndrome. Acute aortic dissection and rupture into the superior vena cava occurred 8 years after aortic valve replacement. The preoperative diagnosis was made by right heart catheterization and computed tomography. A markedly increased left-to-right shunt occurred with rapid enlargement of the fistula due to the fragility of the aortic wall characteristic of Marfan's syndrome. Postmortem examination demonstrated severe medial necrosis with rupture of the aortic wall into the superior vena cava which was adherent to the suture line of the aortotomy from the previous surgery. Type A aortic dissection with severe congestive heart failure strongly suggested rupture into the pulmonary circulation.

Entities:  

Mesh:

Year:  1997        PMID: 9267354

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Aortocaval tunnel to the superior vena cava: a case report.

Authors:  Rezvanieh Salehi; Bahman Rastkar; Abbas Afrasiabi; Leili Pourafkari
Journal:  J Cardiovasc Thorac Res       Date:  2011-05-28

2.  Congenital arteriovenous fistula between descending aorta and the left innominate vein.

Authors:  Sedat Giray Kandemirli; Mete Han Kizilkaya; Basak Erdemli Gursel; Tugberk Akca; Ozlem Mehtap Bostan
Journal:  Surg Radiol Anat       Date:  2019-07-10       Impact factor: 1.246

3.  Congenital aortocaval fistula mimicking atrial septal defect on transthoracic echocardiography.

Authors:  Alaa Quisi; Gülhan Yüksel Kalkan; Ahmet Oytun Baykan; Murat Çaylı
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.